Nanogam (Human Normal Immunoglobulin)

Nanogam is used to replace deficient antibodies in patients with primary or secondary immunodeficiency conditions.

• Primary immunodeficiency diseases (e.g., common variable immunodeficiency): provides IgG antibodies to reduce infection frequency.
• Secondary immunodeficiency (e.g., post‑bone marrow transplant, chemotherapy): supplies passive immunity to protect against opportunistic pathogens.
• Prophylaxis of infections in antibody‑deficient patients: maintains protective antibody levels to prevent bacterial and viral infections.

• Human Normal Immunoglobulin in Nanogam consists of pooled IgG antibodies derived from screened donors. After intravenous infusion, the IgG distributes throughout the vascular and extravascular compartments, binding to pathogens, toxins, and complement components. This neutralizes microbes, facilitates opsonization, and modulates immune cell activity, thereby restoring humoral immunity in individuals lacking adequate antibody production.

Nanogam may be associated with infusion‑related reactions and immune‑mediated events.

Common Side Effects

• Headache: mild to moderate discomfort during or after infusion.
• Fever or chills: transient elevation of body temperature.
• Nausea: mild gastrointestinal upset.
• Fatigue: temporary feeling of tiredness.
• Injection site erythema: redness at the infusion site.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction requiring immediate medical attention.
• Thromboembolic events: blood clots such as deep vein thrombosis.
• Renal impairment: acute kidney injury, especially with high infusion rates.
• Hemolysis: destruction of red blood cells.
• Aseptic meningitis: inflammation of meninges without infection.

When using Nanogam, clinicians should consider several safety and handling precautions.

• Patient assessment: evaluate history of IgA deficiency or allergic reactions to blood products.
• Infusion rate: start slowly and increase gradually to reduce adverse reactions.
• Hydration status: ensure adequate fluid intake to support renal function.
• Monitoring: observe vital signs during infusion and for at least 30 minutes after.
• Concomitant immunosuppressants: assess increased infection risk when combined.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Nanogam can interact with certain medications and clinical conditions.

Major Interactions (Avoid)

• Live vaccines: may reduce vaccine efficacy or increase risk of infection.
• High‑dose aspirin or NSAIDs: increase risk of bleeding due to platelet inhibition.
• Immunoglobulin‑A deficiency with anti‑IgA antibodies: risk of severe anaphylaxis.

Moderate Interactions (Monitor Closely)

• Corticosteroids: may alter immune response, requiring dose adjustment.
• Anticoagulants (e.g., warfarin): monitor coagulation parameters.
• Diuretics: monitor renal function and fluid balance.